News

For the first time, scientists discover that a subset of a common blood cancer is more deadly in women than in men — and find a new targeted treatment approach

May 06, 2026

For the first time, scientists discover that a subset of a common blood cancer is more deadly in women than in men — and find a new targeted treatment approach

May 10, 2021

UFESA donates to the Josep Carreras Leukaemia Research Institute to promote health-related research projects

April 29, 2021

Interview Berta Nieves Vázquez

April 22, 2021

Dr. Anna Bigas, among the "Top 100 Women Leaders"

April 19, 2021

Genetic variants identified that impact immune cells’ functioning

April 15, 2021

Discovery of Epigenetic Factors Predicting the Severity of COVID-19

April 09, 2021

Personalized and precision medicine: the future of tailored treatments discussed at PEMED 2021, chaired by the Josep Carreras Leukaemia Research Institute

March 29, 2021

Sant Pau administers the first CAR-T of its own production for Hodgkin and non-Hodgkin lymphoma T in Europe

March 26, 2021

Success of the first phase-2 clinical trial testing the new CAR-T technology against multiple myeloma

March 24, 2021

Emerging leaders in the field of immunity join together at the Josep Carreras Leukaemia Research Institute

March 03, 2021

The Josep Carreras Research Institute and Cytognos S.L. develop a kit to determine the prognosis of patients diagnosed with Acute Myeloid Leukaemia